Effect of Diacerein on Metabolic Control and Inflammatory Markers in Patients with Type 2 Diabetes Using Antidiabetic Agents: A Randomized Controlled Trial.
Glaucia S TresSandra C FuchsFabiana PiovesanPatricia Koehler-SantosFernanda Dos S PereiraSuzi A CameyHugo K LisboaLeila Beltrami MoreiraPublished in: Journal of diabetes research (2018)
This trial is registered with Brazilian Clinical Trials Registry (ReBEC) number RBR-29j956.